Literature DB >> 15554785

Overview of panic and social anxiety disorders.

Herman G M Westenberg1, Michael R Liebowitz.   

Abstract

Panic disorder and social anxiety disorder are often-overlooked but debilitating disorders that share some common symptoms and treatments. Patients with panic disorder experience unexpected panic attacks and then worry about having more attacks. Those with social anxiety disorder fear doing or saying something embarrassing in social situations. The prevalence of these conditions is about 3% for panic disorder and 13% for social anxiety disorder in the United States and is higher in women than in men. Both disorders are thought to have a familial link and to be related to dysregulation of neurotransmitter systems. Panic and social anxiety disorders are often comorbid with other psychiatric disorders. Medication treatment and/or cognitive-behavioral therapy might need to be continued over the long term to prevent relapse.

Entities:  

Mesh:

Year:  2004        PMID: 15554785

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  8 in total

1.  Neurovascular responses to mental stress in prehypertensive humans.

Authors:  Christopher E Schwartz; John J Durocher; Jason R Carter
Journal:  J Appl Physiol (1985)       Date:  2010-11-04

Review 2.  Efficacy and tolerability of second-generation antidepressants in social anxiety disorder.

Authors:  Richard A Hansen; Bradley N Gaynes; Gerald Gartlehner; Charity G Moore; Ruchi Tiwari; Kathleen N Lohr
Journal:  Int Clin Psychopharmacol       Date:  2008-05       Impact factor: 1.659

3.  Psychiatric disorders and mental health service use among caregivers of advanced cancer patients.

Authors:  Lauren C Vanderwerker; Rachel E Laff; Nina S Kadan-Lottick; Suzanne McColl; Holly G Prigerson
Journal:  J Clin Oncol       Date:  2005-08-29       Impact factor: 44.544

4.  Unhealthy Alcohol Use Associated with Obsessive-Compulsive Symptoms: The Moderating Effects of Anxiety and Depression.

Authors:  Michael P Randazza; Dean McKay; Jafar Bakhshaie; Eric A Storch; Michael J Zvolensky
Journal:  J Obsessive Compuls Relat Disord       Date:  2022-02-08       Impact factor: 1.677

5.  Hippocampal serotonin-2A receptor-immunoreactive neurons density increases after testosterone therapy in the gonadectomized male mice.

Authors:  Emsehgol Nikmahzar; Mehrdad Jahanshahi; Amir Ghaemi; Gholam Reza Naseri; Ali Reza Moharreri; Ahmad Ali Lotfinia
Journal:  Anat Cell Biol       Date:  2016-12-31

6.  Network pharmacology study on the mechanism of Qiangzhifang in the treatment of panic disorder.

Authors:  Run Zhao; Pulin Liu; Anran Song; Jianmin Liu; Qian Chu; Yingnan Liu; Yunyun Jiang; Chengda Dong; Huishan Shi; Zhaojun Yan
Journal:  Ann Transl Med       Date:  2021-08

7.  A comparison of low-dose risperidone to paroxetine in the treatment of panic attacks: a randomized, single-blind study.

Authors:  James M Prosser; Samantha Yard; Annie Steele; Lisa J Cohen; Igor I Galynker
Journal:  BMC Psychiatry       Date:  2009-05-26       Impact factor: 3.630

8.  Duration of untreated illness in panic disorder: a poor outcome risk factor?

Authors:  A Carlo Altamura; Annalisa Santini; Daniele Salvadori; Emanuela Mundo
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.